From: Integrative analysis reveals disease-associated genes and biomarkers for prostate cancer progression
No. Exp. | Platform | No. Probes | Samples Series | No. Samples of prostate cancer stages | References | ||||
---|---|---|---|---|---|---|---|---|---|
 |  |  |  | NAP | BN | PCA | MET |  | |
 |  |  |  | (I) | (II) | (III) | (IV) |  | |
 |  |  |  | Early phase | Middle phase | Late phase |  | ||
Exp-1 | Affymetrix HG-U133P2 | GPL570 | 54,675 | GSE3325 | 0 | 6 | 7 | 6 | [76] |
Exp-2 | cDNAChinnaiyan Human 20K Hs6 | GPL2013 | 20,000 | GES6099 | 0 | 15 | 32 | 20 | [77] |
Exp-3 | Agilent-014850 4x44K G4112F | GPL4133 | 45,220 | GSE27616 | 0 | 2 | 5 | 4 | [78] |
Exp-4 | Affymetrix HG-U133A | GPL96 | 22,283 | GSE3868 | 2 | 0 | 22 | 0 | [79] |
Exp-5 | Affymetrix HGU95A | - | 12,626 | - | 9 | 0 | 25 | 0 | [80] |
Exp-6 | Affymetrix HG-U133P2 | GPL570 | 54,675 | GSE17951 | 0 | 45 | 109 | 0 | |
Exp-7 | Agilent-014850 4x44K G4112F | GPL6480 | Â | GSE28204 | 0 | 4 | 4 | 0 | [83] |
Exp-8 | Affymetrix HG_U95Av2 | GPL8300 | 12,625 | GSE6919 | 18 | 0 | 65 | 25 |